Operating income decreased 51.0%
Operating income changed -51.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -51.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current ratio changed -66.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -4468 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed +90.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash flow changed -16.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed -52.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Total assets changed -45.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.